Written by Editorial Staff
Thu, Dec 21 2006
FURTHER READING
IBA Molecular has entered into an agreement with Munich, Germany-based WILEX AG, through which IBA will radiolabel the WILEX antibody WX-G250 with Iodine-124 and will distribute the PET diagnostic agent to clinical trials sites worldwide.
|
